Investor profile
SICC Innvierte fund has backed 2 European tech companies across 2 funding rounds in 2026, joining rounds totalling €23M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Telum Therapeutics | Spain | 1 | €18M |
| Peptomyc | Spain | 1 | €5.0M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Telum Therapeutics | Series A | €18M | 2026-07 |
| Peptomyc | Other | €5.0M | 2026-04 |
